Tpharm.info


Zimovane





I have recently been prescribed Zimovane 7.5mg and have.Thread

12/22/2014
08:18 | Author: Emma Coleman

Zimovane
I have recently been prescribed Zimovane 7.5mg and have.Thread

I have recently been prescribed Zimovane 7.5mg and have used them on 3 occasions to combat the effects of insomnia that is a side effect of.

Egton Medical Information Systems Limited. Registered in England. No 2117205 Registered Office: Rawdon House, Green Lane, Yeadon, Leeds LS19 7BY is a UK registered trade mark. Trending search phrases: bmi calculator, scarlet fever, blood pressure, cystic fibrosis, pregnancy symptoms, glandular fever, multiple sclerosis, prostate cancer, depression test, rheumatoid arthritis.

As with all drugs.

Help choosing the right treatment.

Receive accolades for helping out other members of the community.

No significant side effects apart from being drowsy first 30 minutes afte waking.

Yes, I have been taking Zimovane on and off for about 3 years.

Comments (1)Read more



Zimovane LS 3.75mg film-coated tablets - Summary of Product

10/21/2014
06:24 | Author: Lauren Ross

Zimovane
Zimovane LS 3.75mg film-coated tablets - Summary of Product

Zimovane LS 3.75mg film-coated tablets. 2. Qualitative and quantitative composition. Zopiclone 3.75 mg. For full list of excipients, see section.

Rare: urticaria or rash, pruritus Musculoskeletal and connective tissue disorders.

A reduced dosage is recommended, see Posology. Benzodiazepines are not indicated to treat patients with severe hepatic insufficiency as they may precipitate encephalopathy (see Contraindications) Use in renal insufficiency.

Find medicines from the same company.

Zimovane 7.5mg & Zimovane LS 3.75mg film-coated tablets (PIL).

Before you contact this company : often several companies will market medicines with the same active ingredient.

Comments (2)Read more

Zimovane 7.5mg Zimovane LS 3.75mg film-coated tablets - X-PIL

8/20/2014
04:14 | Author: Emma Coleman

Zimovane
Zimovane 7.5mg Zimovane LS 3.75mg film-coated tablets - X-PIL

The name of your medicine is Zimovane tablets or Zimovane LS tablets (both called Zimovane in this leaflet). Zimovane contains a medicine called zopiclone.

Before taking Zimovane, it is important to make sure that you can have at least 7 to 8 hours of uninterrupted sleep to help reduce the risk of some side effects (see section 4 – Possible side effects).

sanofi, 1993 - 2013 R769460.

Store below 30°C. Keep the blister in the outer carton in order to protect from light and moisture.

Not known (frequency cannot be estimated from available data).

Zimovane is used to treat sleep problems such as:

Zimovane should not be used in children and adolescents under 18 years of age.

Do not take a double dose to make up for a forgotten tablet.

Treatment should be as short as possible and should not exceed four weeks including period of tapering off.

Like all medicines, Zimovane can cause side effects, although not everybody gets them.

You may be able to get this leaflet in large print, Braille or as an audio CD, call the RNIB Medicine Leaflet line on 0800 198 5000 for more information.

This leaflet was last revised in 06/2013.

Taking too much Zimovane can be very dangerous.

Comments (3)Read more

ZIMOVANE 7.5MG FILM-COATED TABLETS

6/19/2014
02:32 | Author: David Perry

Zimovane
ZIMOVANE 7.5MG FILM-COATED TABLETS

Patient information for ZIMOVANE 7.5MG FILM-COATED TABLETS Including dosage instructions and possible side effects.

Follow: Google+ Facebook Twitter YouTube RSS.

Data sources include Micromedex (updated Sep 26th, 2014), Cerner Multum (updated Oct 16th, 2014), Wolters Kluwer (updated Oct 9th, 2014) and others. To view content sources and attributions, refer to our editorial policy.

Active substance: ZOPICLONE Expand view ⇕

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist. More FDA updates.

Source: Medicines and Healthcare Products Regulatory Agency.

provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment.

We comply with the HONcode standard for trustworthy health information. Verify here.

Terms of Use · Privacy Policy.

Comments (0)

Zimovane - medicines and drugs - NHS Choices

4/18/2014
12:30 | Author: David Perry

Zimovane
Zimovane - medicines and drugs - NHS Choices

Zimovane is the brand name for this medicine. It is available as the following generic version. Please select one of the medicines below for information about.

Have pages recommended to you.

Keep track of important pages.

Exercise your right to choice in the NHS.

Get Your Health newsletters Sign up.

Already have an account? Log in.

Easily find again pages you have been reading.

NHS Choices offers a range of e-newsletters on various topics. Sign up now to get information, tips and advice straight to your inbox.

With an account you can keep track of pages on the site and save them to this tab, which you can access on every page when you are logged in. Create account.

zimovane is the brand name for this medicine. It is available as the following generic version. Please select one of the medicines below for information about zimovane.

Learn about patient choice now.

Don't miss out.

Your health, your choices Information navigation Main navigation.

Sign up for Your Health, the monthly e-newsletter packed with the latest news and topical tips from NHS Choices.

Comments (0)